Dutalys Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $489M

Dutalys General Information

Description

Developer of human, bi-specific antibodies used in drugs. The company specializes in the discovery and development of bi-specific and monoclonal antibodies used in pharmaceutical and therapeutic drugs.

Contact Information

Website
www.dutalys.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Roche
Vertical(s)
Life Sciences
Corporate Office
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dutalys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 18-Dec-2014 $489M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Dutalys’s complete valuation and funding history, request access »

Dutalys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human, bi-specific antibodies used in drugs. The company specializes in the discovery and development of bi
Biotechnology
Vienna, Austria

Carlsbad, CA

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dutalys Competitors (33)

One of Dutalys’s 33 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Kodiak Sciences Formerly VC-backed Palo Alto, CA
Gritstone bio Formerly VC-backed Emeryville, CA
Mustang Bio Formerly VC-backed Worcester, MA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 33 competitors. Get the full list »

Dutalys Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
INiTS Universitäres Gründerservice Accelerator/Incubator
To view Dutalys’s complete investors history, request access »

Ready to get started?

Request a free trial

Dutalys FAQs

  • When was Dutalys founded?

    Dutalys was founded in 2010.

  • Where is Dutalys headquartered?

    Dutalys is headquartered in Vienna, Austria.

  • What industry is Dutalys in?

    Dutalys’s primary industry is Biotechnology.

  • Is Dutalys a private or public company?

    Dutalys is a Private company.

  • What is the current valuation of Dutalys?

    The current valuation of Dutalys is .

  • What is Dutalys’s current revenue?

    The current revenue for Dutalys is .

  • Who are Dutalys’s investors?

    INiTS Universitäres Gründerservice has invested in Dutalys.

  • Who are Dutalys’s competitors?

    Renova Therapeutics, Kodiak Sciences, Gritstone bio, Mustang Bio, and CytomX Therapeutics are some of the 33 competitors of Dutalys.

  • When was Dutalys acquired?

    Dutalys was acquired on 18-Dec-2014.

  • Who acquired Dutalys?

    Dutalys was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »